Chhattisgarh, long known as the epicentre of Left-wing extremism, clocked the highest growth rate among all states in 2009-10. The emergence of the state as a ‘miracle economy’ is yet to loosen the grip of politics of misery-mongering. Chief minister Raman Singh discusses the state’s growth journey and its challenges with Bharti Jain. Chhattisgarh is the latest growth story, having ranked first among states with 11.49% growth rate. What are...

Chief economic advisor to the finance ministry Kaushik Basu says the government should step in and acquire land for development projects to protect the interests of farmers. He also explains why the government cannot tackle food inflation by distributing free foodgrain among the poor. Excerpts from interview with ET: A large number of land-intensive project have run into opposition. Could it actually undermine our infrastructure thrust and growth? There is...

Exaggeration. Exaggeration. Exaggeration.  I was subjected to this tiresome litany from various angry officials and a couple of politicians after one of their colleagues — who will remained unnamed — leaked to me the perilous state of India’s granaries and the rotting foodgrain within. On July 26, I reported how 50,000 metric tonnes of wheat and rice had rotted away, unfit even for animals; how 17.8 million tonnes, enough to feed...

When noted economist Jean Dreze visited Surguja in Chhattisgarh a decade ago, its utterly non-functional Public Distribution System (PDS) looked like especially “designed to fail.” The National Advisory Committee member has written in a recent article that the ration shop owners illegally sold the grain meant for the poor and “hunger haunted the land.” But that was then. The economist was pleasantly shocked to see the transformation this time. “Ten years...

No clarity on which authorities will be competent or which laws will be relevant: Ramesh He agrees with the compromise of Department of S&T as the nodal Ministry The Biotechnology Regulatory Authority of India (BRAI) will only deal with the safety and efficacy aspects of biotech products, leaving the controversial commercialisation aspect hanging in the air, according to the latest version of the BRAI Bill, 2010. The Bill, which was supposed to be...